Related Experiment Video

Updated: Jul 19, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway

Arianna Nicolussi1, Sonia D'Inzeo, Angela Gismondi

  • 1Department of Experimental Medicine and Pathology, University La Sapienza, V.le Regina Elena, 324, 00161 Rome, Italy.

Clinical & Experimental Metastasis
|November 7, 2006
PubMed

Insights

Restoring the Transforming Growth Factor-beta receptor type II (TbetaRII) in K-ras-transformed thyroid cells reduces their malignant behavior. Overexpressing TbetaRII decreases cell growth, migration, and tumor spread, suggesting a therapeutic target for thyroid cancer.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Transforming Growth Factor-beta1 (TGF-β1) regulates crucial cellular processes via TGF-β receptors.
  • K-ras-transformed rat thyroid cells (K10) exhibit resistance to TGF-β1 due to decreased TbetaRII expression.
  • Previous studies showed TbetaRII transfection partially reverts malignant phenotype and reduces tumorogenicity.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the modulation of tumorigenic potential in K-ras-transformed thyroid cells overexpressing TbetaRII.
  • To confirm the functionality of overexpressed TbetaRII in restoring normal cellular behavior.

Main Methods:

  • Transfection of TbetaRII into K-ras-transformed rat thyroid cells.
  • Assessment of anchorage-dependent and -independent cell growth.
  • Evaluation of tumorogenicity in athymic nude mice (spontaneous and artificial metastases).
  • Analysis of cell adhesion and migration behaviors.

Main Results:

  • Overexpression of TbetaRII in K-ras-transformed thyroid cells results in a functional receptor.
  • TbetaRII overexpression restores normal cellular behavior, reducing anchorage-dependent and -independent growth.
  • Significant reduction in tumorogenicity and metastatic potential observed in TbetaRII-overexpressing clones.
  • Reduced adhesive and migratory behavior in highly malignant K-ras-transformed thyroid cells with TbetaRII overexpression.

Conclusions:

  • Restoring functional TGF-beta receptor type II (TbetaRII) in K-ras-transformed thyroid cells is essential for reverting malignant phenotypes.
  • TbetaRII overexpression significantly diminishes the aggressive characteristics of these cancer cells.
  • Targeting TbetaRII expression may offer a strategy to limit tumor spread and dissemination in thyroid cancer.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...